Express Pharma
Home  »  Latest Updates  »  Zydus Cadila gets US FDA nod for drug used to reduce swelling

Zydus Cadila gets US FDA nod for drug used to reduce swelling

48
Read Article

The company will produce the drug at its formulations manufacturing facility in Moraiya, Ahmedabad

Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling caused by various diseases.

The company has received final approval from the US Food and Drug Administration (US FDA) to market the drug in the strength of 50 mg/vial, Zydus Cadila said in a BSE filing.

The company will produce the drug at its formulations manufacturing facility in Moraiya, Ahmedabad.

Ethacrynate sodium for injection is used to reduce swelling caused by various diseases including diseases related to the liver, kidney, congestive heart failure and cancer.

The company has more than 165 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.

Comments are closed.

Virtual Conference

PHARMA PACKAGING AND LABELLING CONCLAVE

Attend India's Largest Pharma Packaging & Labelling Conclave & Attend LIVE sessions by Industry experts.
REGISTER NOW
close-link
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Attend India's Largest Pharma Packaging & Labelling Conclave
Register Now
close-image